期刊
DIABETES
卷 61, 期 2, 页码 383-390出版社
AMER DIABETES ASSOC
DOI: 10.2337/db11-0305
关键词
-
资金
- le Conseil Regional Nord Pas de Calais/Fonds Europeen de Developpement Regional
- Agence Nationale de la Recherche, Innovation Through Science and Technology in Flanders IWT-Vlaanderen [GOA2008/16]
- Deutsche Forschungsgemeinschaft [TH862/1-4]
- Medical Research Council [G0801056B, G0801056] Funding Source: researchfish
- MRC [G0801056] Funding Source: UKRI
Null mutations in the PCSK1 gene, encoding the proprotein convertase 1/3 (PC1/3), cause recessive monogenic early onset obesity. Frequent coding variants that modestly impair PC1/3 function mildly increase the risk for common obesity. The aim of this study was to determine the contribution of rare functional PCSK1 mutations to obesity. PCSK1 exons were sequenced in 845 nonconsanguineous extremely obese Europeans. Eight novel nonsynonymous PCSK1 mutations were identified, all heterozygous. Seven mutations had a deleterious effect on either the maturation or the enzymatic activity of PC 1/3 in cell lines. Of interest, five of these novel mutations, one of the previously described frequent variants (N221D), and the mutation found in an obese mouse model (N222D), affect residues at or near the structural calcium binding site Ca-1. The prevalence of the newly identified mutations was assessed in 6,233 obese and 6,274 lean European adults and children, which showed that carriers of any of these mutations causing partial PCSK1 deficiency had an 8.7-fold higher risk to be obese than wild-type carriers. These results provide the first evidence of an increased risk of obesity in heterozygous carriers of mutations in the PCSK1 gene. Furthermore, mutations causing partial PCSK1 deficiency are present in 0.83% of extreme obesity phenotypes. Diabetes 61:383-390, 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据